Vyne Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Vyne Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Vyne Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vyne Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $48 | 146 | 0.33 |
| 2025-03-31 | $9.4k | 6.0k | 1.58 |
| 2024-12-31 | $1.1k | 314 | 3.35 |
| 2024-09-30 | $332 | 177 | 1.88 |
| 2024-06-30 | $346 | 176 | 1.97 |
| 2024-03-31 | $528 | 169 | 3.13 |
| 2023-12-31 | $346 | 146 | 2.38 |
| 2023-09-30 | $584 | 146 | 4.00 |
| 2023-06-30 | $32 | 8 | 4.00 |
| 2023-03-31 | $0 | 8 | 0.00 |